IL33-ST2 axis is a predictive biomarker for anti-PD1 therapeutic efficacy in advanced gastric cancer.
Saved in:
| Title: | IL33-ST2 axis is a predictive biomarker for anti-PD1 therapeutic efficacy in advanced gastric cancer. |
|---|---|
| Authors: | Kudo-Saito, Chie1 (AUTHOR) ckudo@ncc.go.jp, Imazeki, Hiroshi1,2 (AUTHOR), Nagashima, Kengo3 (AUTHOR), Shoji, Hirokazu2 (AUTHOR), Tsugaru, Kai4 (AUTHOR), Takahashi, Naoki5 (AUTHOR), Kawakami, Takeshi6 (AUTHOR), Amanuma, Yusuke7 (AUTHOR), Wakatsuki, Takeru8 (AUTHOR), Okano, Naohiro9 (AUTHOR), Narita, Yukiya10 (AUTHOR), Yamamoto, Yoshiyuki11 (AUTHOR), Kizawa, Rika12 (AUTHOR), Muro, Kei10 (AUTHOR), Ichikawa, Hitoshi13 (AUTHOR), Boku, Narikazu2,14 (AUTHOR) |
| Source: | Journal of Translational Medicine. 10/17/2025, Vol. 23 Issue 1, p1-13. 13p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
